Swedish Orphan Biovitrum AB | Key People and Executives
Lena Elisabeth Svanberg
Director
Sven Håkan Björklund
Chairman
Annette V. Clancy
Independent Director
Matthew Gantz
Independent Director
Erling Lennart Johansson
Independent Director
Guido Oelkers
President & Chief Executive Officer
Mats-Olof Wallin
Chief Financial Officer & Senior Vice President
Kristina Sjoblom Nygren
Head-Clinical Development
Milan Zdravkovic
Chief Medical Officer, Head-Research & Development
Philip Wood
Senior Vice President & Head-Haemophilia
Armin Reininger
SVP, Head-Global Medical & Scientific Affairs
Rami Levin
President-North America
Holly May
Vice President-Sales & Marketing US Region
Norbert Oppitz
Senior Vice President-Specialty Care
Stephen James
VP, Head-Research & Translational Sciences
Kirsti Gjellan
SVP, Head-Biologics Development & Supply
Lars Dreiøe
Chief Quality & Compliance Officer, Senior VP
An van Es Johansson
Vice President
Lena Elisabeth Svanberg
Director
Jörgen Winroth
Vice President & Head-Investor Relations
Fredrik Wetterlundh
Head-Human Resources
Per Richard Torbjörn Hallberg
General Counsel & Head-Legal Affairs
Sven Håkan Björklund
Chairman
Annette V. Clancy
Independent Director
Matthew Gantz
Independent Director
Erling Lennart Johansson
Independent Director
| Address |
Tomtebodavägen 23A
Solna AB 112 76
Sweden
|
|
Employees
|
- |
| Website |
http://www.sobi.com |
| Updated |
07/08/2019 |
| Swedish Orphan Biovitrum AB engages as a biopharmaceutical company. It provides therapies and services for patients with rare diseases. The firm's core products include Kineret within the inflammation therapeutic area; and Orfadin, Ammonaps, and Ammonul within the genetics and metabolic therapeutic area. |
